Illumina is a biotechnology company that specializes in genetic sequencing and analysis. Founded in 1998, it has become a leader in the development of innovative tools and technologies for genomics research. Their products are widely used in various fields, including medicine, agriculture, and environmental science. The company's most notable technology is its next-generation sequencing (NGS) platforms, which allow researchers to quickly and accurately read DNA sequences. This capability has revolutionized the study of genetics, enabling advancements in personalized medicine, cancer research, and genetic disease understanding.